Fulvio D'acquisto

Personal details

Name: Fulvio Surname: D’Acquisto

Date of birth: 13th May 1970

Nationality: Italian

Email: [email protected]

Telephone: 07743726415

Professional profile

• Over 25 years of academic translational research in inflammation and autoimmunity with a particular focus on both innate and adaptive immune cells.

• Lead scientist and inventor for 3 patents and 3 licenses that have led to the generation of new biotech or a new line of research for Biopharma.

• Obtained UK research funding totaling £2,080,239 - a quarter of this through research consultancy for startups and pharmaceutical companies.

• Author and co-author of more than 100 publications (60% as first or last author).

• RAE-returned in 2008 and REF-returned staff in 2014, 2021

• Awarded the first round of Medical Research Council New Investigator Award.

• An active member of the Editorial Board of 8 peer-reviewed international journals in the field of Pharmacology, Immunology and Interdisciplinary Biomedical Research.

• Extensive experience in undergraduate and postgraduate teaching.

• Passionate advocate for Public Engagement in Science and Research

• Fellow of the Royal Society of Biology

Work experience

Director, Health Science Centre & Professor of Immunology - University of Roehampton (January 2018-).

• Leading the submission of REF Environment statement (UoA3) for Health Science Research Centre

• Managing and mentoring a group of 13 staff members

• Promoting a new way to foster knowledge exchange with external companies

• Leading a pre-clinical research program for a new biotech Oxford Cannabinoid Technologies

• Sole inventor for a patent and a license on Immuno-moodulin

Co-Director, Biochemical Pharmacology - William Harvey Research Institute (July 2014-September 2017)

• Managing and mentoring a group of 15 staff members

• Managing a communal budget for shared research consumable and equipment

• Representing the Centre at Senior Management meetings

Biomedical Research Lead for the Life Science Institute – Queen Mary University of London (January 2014-July 2016)

• Designing the strategy and structure of the Biomedical Domain in terms of research and teaching

• Reporting the activity of the Life Science Institute committee to other senior managers

Professor in Immunology and Immunopharmacology - Queen Mary University of London (July 2014-September 2017)

• Supervision of 5 PhD students to completion

• Published 22 papers as leading or co-leading author

• The successful design of a new Pharmacology module for the undergraduate degree in Pharmacology and Innovation.

• Two patent applications, one of which has been licensed to Medannex

• Collaborative project (PhD studentship) with UCB.

Reader in Immunopharmacology - Queen Mary University of London (July 2009 -June 2014)

• Supervision of 2 PhD students and 2 postdoctoral researchers

• Research funding from the British Heart Foundation and Medical Research Funding

• Published 33 papers as leading or co-leading author

• One patent application and one license to Medannex

Senior Lecturer in Immunopharmacology - Queen Mary University of London (September 2004 -June 2009)

• Medical Research Council New Investigator award

• Supervision of 1 PhD and 1 postdoctoral researcher

• Funding from the Multiple Sclerosis Society and Arthritis Research UK

• Published 14 papers as leading or co-leading author

Postdoctoral research associate, Immunobiology - Yale University, USA (December 1999 – July 2003)

• Howard Huges Medical Institute-funded postdoctoral position

• Leading several research projects on new ways to target NF-kB in inflammation and autoimmunity

• Authored 2X Science, 1 Immunity and 1 Nature Medicine paper

• Submission of my first patent on targeting PKC theta and the Immune Synapse in autoimmune diseases

Visiting scientist at the Investigative Treatment Division of the National Cancer Center Research Institute East in Kashiwa, Japan (March 1998 – September 1998)

• Characterization of the promoter region of iNOS promoter and its modulation by hypoxia

Visiting Researcher at the Department of Gastroenterology of the University of Calgary, Canada (July 1994 – December 1994)

• Testing Cox-1/Cox-2 selectivity of new non-gastrolesive anti-inflammatory compounds.

Academic qualifications

• PhD in Experimental Pharmacology – University of Naples “Federico II” (September 1996 - December 1999)

• Master in Experimental Pharmacology - University of Naples “Federico II” (September 1994 - August 1996)

• Degree in Pharmaceutical Chemistry - University of Naples “Federico II” (September 1988 - July 1994)

Please see https://orcid.org/0000-0002-4513-1608